Literature DB >> 19125083

A nationwide survey of newly diagnosed childhood idiopathic thrombocytopenic purpura in Japan.

Akira Shirahata1, Kohji Fujisawa, Eiichi Ishii, Shigeru Ohta, Masahiro Sako, Yukihiro Takahashi, Masashi Taki, Jun-Ichi Mimaya, Masaru Kubota, Takuma Miura, Junichi Kitazawa, Michiko Kajiwara, Fumio Bessho.   

Abstract

BACKGROUND: We evaluated the clinical pictures, outcome for childhood idiopathic thrombocytopenic purpura (ITP) and the trends of the choice of management for childhood ITP in Japan.
METHOD: Every year, questionnaires were sent to all institutions that employ the active members of the Japanese Society of Pediatric Hematology. The questionnaires included age, sex, date of diagnosis, platelet count at diagnosis, the presence or absence of antecedent infection, hemorrhagic symptoms, initial management, and the outcome of all patients newly diagnosed with ITP.
RESULTS: A total of 986 newly diagnosed as ITP patients were reported between January 2000 and December 2005. The occurrence of ITP peaked in boys less than 1 year of age, and at 1 year of age in girls. The male-to-female ratio was 1.24:1. Wet purpura was observed in more than half of the patients with platelet counts of <10,000/microL. The initial treatment varied among the patients with different platelet counts at diagnosis; most of the patients with platelet counts <20,000/microL received intravenous immunoglobulin or oral corticosteroids. Conversely, cases without any aggressive treatment increased to a larger degree in patients with > or =20,000/microL of platelet.
CONCLUSIONS: These findings indicate that overall compliance to the Japanese guideline is considered to be relatively good in Japan.

Entities:  

Mesh:

Year:  2009        PMID: 19125083     DOI: 10.1097/MPH.0b013e318190d44e

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  4 in total

1.  Newly diagnosed immune thrombocytopenia in children and adults: a comparative prospective observational registry of the Intercontinental Cooperative Immune Thrombocytopenia Study Group.

Authors:  Thomas Kühne; Willi Berchtold; Lisa A Michaels; Runhui Wu; Hugo Donato; Bibiana Espina; Hannah Tamary; Francesco Rodeghiero; Meera Chitlur; Johannes Rischewski; Paul Imbach
Journal:  Haematologica       Date:  2011-08-31       Impact factor: 9.941

2.  Characterization of chronic idiopathic thrombocytopenic purpura in Japanese children: a retrospective multi-center study.

Authors:  Masaru Kubota; Souichi Adachi; Ikuya Usami; Masayuki Okada; Toshiyuki Kitoh; Mitsutaka Shiota; Yoshihiro Taniguchi; Akihiko Tanizawa; Mitsuhiko Nanbu; Keigo Hamahata; Hisanori Fujino; Kousaku Matsubara; Yoshihiro Wakazono; Tatsutoshi Nakahata
Journal:  Int J Hematol       Date:  2010-01-05       Impact factor: 2.490

3.  Incidence and outcomes of refractory immune thrombocytopenic purpura in children: a retrospective study in a single institution.

Authors:  Masataka Ito; Hiroshi Yagasaki; Koji Kanezawa; Katsuyoshi Shimozawa; Maiko Hirai; Ichiro Morioka
Journal:  Sci Rep       Date:  2021-07-12       Impact factor: 4.379

4.  Immune thrombocytopenic purpura risk by live, inactivated and simultaneous vaccinations among Japanese adults, children and infants: a matched case-control study.

Authors:  Hiroshi Yokomichi; Keiko Tanaka-Taya; Rie Koshida; Takashi Nakano; Yoshinori Yasui; Masaaki Mori; Yuka Ando; Saeko Morino; Hideo Okuno; Hiroshi Satoh; Satoru Arai; Mie Mochizuki; Zentaro Yamagata
Journal:  Int J Hematol       Date:  2020-04-06       Impact factor: 2.319

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.